Reaction
Cervicogenic Headache reporting signals
As of the last recalculation, Cervicogenic Headache appears in 132 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE (PRR 385.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 18 | 385.3 | 386.1 |
| Rizatriptan Benzoate | 15 | 262.2 | 262.6 |
| Sumatriptan Succinate | 21 | 155.6 | 155.7 |
| Naltrexone | 18 | 106.5 | 106.5 |
| Onabotulinumtoxina | 24 | 59.7 | 59.7 |
| Erenumab-Aooe | 8 | 24.3 | 24.3 |